Macomber Lori

Macomber Lori is listed in filings as EVP at Karyopharm Therapeutics Inc.. This profile follows SEC Form 4 activity through Feb 4, 2026, including sale activity. Recent filings connect the profile to Karyopharm Therapeutics Inc. (KPTI). The current snapshot covers public activity from Feb 3, 2025 to Feb 4, 2026. Reported amounts are shown as $10.2K to $404.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.